nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethylmorphine—CYP2B6—Raloxifene—osteoporosis	0.143	0.144	CbGbCtD
Ethylmorphine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.138	0.139	CbGbCtD
Ethylmorphine—CYP2B6—Cholecalciferol—osteoporosis	0.111	0.111	CbGbCtD
Ethylmorphine—CYP3A7—Estradiol—osteoporosis	0.0936	0.0939	CbGbCtD
Ethylmorphine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0936	0.0939	CbGbCtD
Ethylmorphine—CYP3A4—Estropipate—osteoporosis	0.066	0.0662	CbGbCtD
Ethylmorphine—CYP3A4—Calcitriol—osteoporosis	0.066	0.0662	CbGbCtD
Ethylmorphine—CYP2D6—Cholecalciferol—osteoporosis	0.0534	0.0536	CbGbCtD
Ethylmorphine—CYP3A4—Ergocalciferol—osteoporosis	0.0527	0.0529	CbGbCtD
Ethylmorphine—CYP3A4—Raloxifene—osteoporosis	0.044	0.0442	CbGbCtD
Ethylmorphine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0425	0.0426	CbGbCtD
Ethylmorphine—CYP3A4—Cholecalciferol—osteoporosis	0.034	0.0341	CbGbCtD
Ethylmorphine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0312	0.0313	CbGbCtD
Ethylmorphine—CYP3A4—Estradiol—osteoporosis	0.0274	0.0275	CbGbCtD
Ethylmorphine—POR—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000408	0.127	CbGpPWpGaD
Ethylmorphine—POR—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000214	0.0668	CbGpPWpGaD
Ethylmorphine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000184	0.0574	CbGpPWpGaD
Ethylmorphine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	6.95e-05	0.0217	CbGpPWpGaD
Ethylmorphine—CYP3A7—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	6.86e-05	0.0214	CbGpPWpGaD
Ethylmorphine—OPRM1—IL4-mediated signaling events—COL1A2—osteoporosis	6.57e-05	0.0205	CbGpPWpGaD
Ethylmorphine—CYP3A7—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	5.63e-05	0.0176	CbGpPWpGaD
Ethylmorphine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	5.14e-05	0.016	CbGpPWpGaD
Ethylmorphine—CYP2B6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	5.07e-05	0.0158	CbGpPWpGaD
Ethylmorphine—OPRM1—IL4-mediated signaling events—COL1A1—osteoporosis	5.05e-05	0.0157	CbGpPWpGaD
Ethylmorphine—OPRM1—G-protein activation—POMC—osteoporosis	4.83e-05	0.0151	CbGpPWpGaD
Ethylmorphine—OPRM1—TCR Signaling Pathway—NFATC1—osteoporosis	4.63e-05	0.0144	CbGpPWpGaD
Ethylmorphine—CYP2B6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.17e-05	0.013	CbGpPWpGaD
Ethylmorphine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.72e-05	0.0116	CbGpPWpGaD
Ethylmorphine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.65e-05	0.0114	CbGpPWpGaD
Ethylmorphine—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.6e-05	0.0112	CbGpPWpGaD
Ethylmorphine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	3.57e-05	0.0111	CbGpPWpGaD
Ethylmorphine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	3.53e-05	0.011	CbGpPWpGaD
Ethylmorphine—CYP3A7—Biological oxidations—CYP27A1—osteoporosis	2.99e-05	0.00933	CbGpPWpGaD
Ethylmorphine—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.96e-05	0.00922	CbGpPWpGaD
Ethylmorphine—OPRM1—IL4-mediated signaling events—IRS2—osteoporosis	2.96e-05	0.00921	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metapathway biotransformation—CYP27A1—osteoporosis	2.95e-05	0.0092	CbGpPWpGaD
Ethylmorphine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	2.94e-05	0.00916	CbGpPWpGaD
Ethylmorphine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	2.9e-05	0.00902	CbGpPWpGaD
Ethylmorphine—OPRM1—Opioid Signalling—ADCY5—osteoporosis	2.73e-05	0.0085	CbGpPWpGaD
Ethylmorphine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.7e-05	0.00841	CbGpPWpGaD
Ethylmorphine—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.66e-05	0.0083	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—PTH1R—osteoporosis	2.58e-05	0.00805	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—CALCR—osteoporosis	2.58e-05	0.00805	CbGpPWpGaD
Ethylmorphine—OPRM1—IL4-mediated signaling events—IRS1—osteoporosis	2.58e-05	0.00804	CbGpPWpGaD
Ethylmorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	2.34e-05	0.00728	CbGpPWpGaD
Ethylmorphine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	2.3e-05	0.00718	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—CYP27A1—osteoporosis	2.21e-05	0.0069	CbGpPWpGaD
Ethylmorphine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	2.2e-05	0.00686	CbGpPWpGaD
Ethylmorphine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.19e-05	0.00684	CbGpPWpGaD
Ethylmorphine—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.19e-05	0.00682	CbGpPWpGaD
Ethylmorphine—OPRM1—G alpha (i) signalling events—CNR2—osteoporosis	2.19e-05	0.00681	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metapathway biotransformation—CYP27A1—osteoporosis	2.18e-05	0.0068	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	2.03e-05	0.00632	CbGpPWpGaD
Ethylmorphine—OPRM1—Opioid Signalling—POMC—osteoporosis	2.01e-05	0.00625	CbGpPWpGaD
Ethylmorphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.89e-05	0.0059	CbGpPWpGaD
Ethylmorphine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.88e-05	0.00585	CbGpPWpGaD
Ethylmorphine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.85e-05	0.00577	CbGpPWpGaD
Ethylmorphine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.78e-05	0.00554	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	1.74e-05	0.00541	CbGpPWpGaD
Ethylmorphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.69e-05	0.00526	CbGpPWpGaD
Ethylmorphine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.62e-05	0.00506	CbGpPWpGaD
Ethylmorphine—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	1.57e-05	0.0049	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	1.55e-05	0.00483	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	1.54e-05	0.00479	CbGpPWpGaD
Ethylmorphine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.52e-05	0.00474	CbGpPWpGaD
Ethylmorphine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.52e-05	0.00473	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	1.52e-05	0.00473	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—CALCR—osteoporosis	1.46e-05	0.00455	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—PTH1R—osteoporosis	1.46e-05	0.00455	CbGpPWpGaD
Ethylmorphine—OPRM1—TCR Signaling Pathway—IL1B—osteoporosis	1.37e-05	0.00426	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—PTH—osteoporosis	1.36e-05	0.00423	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—CALCR—osteoporosis	1.33e-05	0.00413	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—PTH1R—osteoporosis	1.33e-05	0.00413	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—CNR2—osteoporosis	1.32e-05	0.00412	CbGpPWpGaD
Ethylmorphine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.32e-05	0.0041	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—WNT1—osteoporosis	1.24e-05	0.00388	CbGpPWpGaD
Ethylmorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.23e-05	0.00382	CbGpPWpGaD
Ethylmorphine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.21e-05	0.00377	CbGpPWpGaD
Ethylmorphine—OPRM1—G alpha (i) signalling events—ADCY5—osteoporosis	1.16e-05	0.00363	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	1.16e-05	0.00362	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—MGLL—osteoporosis	1.16e-05	0.00362	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	1.15e-05	0.00357	CbGpPWpGaD
Ethylmorphine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.13e-05	0.00351	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—PTHLH—osteoporosis	1.12e-05	0.00351	CbGpPWpGaD
Ethylmorphine—OPRM1—TCR Signaling Pathway—TGFB1—osteoporosis	1.06e-05	0.00331	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—MGLL—osteoporosis	1.05e-05	0.00328	CbGpPWpGaD
Ethylmorphine—OPRM1—Peptide ligand-binding receptors—POMC—osteoporosis	1.01e-05	0.00316	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.01e-05	0.00313	CbGpPWpGaD
Ethylmorphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.95e-06	0.0031	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	9.92e-06	0.00309	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—CALCA—osteoporosis	9.9e-06	0.00309	CbGpPWpGaD
Ethylmorphine—CYP3A7—Biological oxidations—POMC—osteoporosis	9.45e-06	0.00294	CbGpPWpGaD
Ethylmorphine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.14e-06	0.00285	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—PKM—osteoporosis	8.91e-06	0.00278	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—FDPS—osteoporosis	8.91e-06	0.00278	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—SOST—osteoporosis	8.66e-06	0.0027	CbGpPWpGaD
Ethylmorphine—OPRM1—G alpha (i) signalling events—POMC—osteoporosis	8.56e-06	0.00267	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GPD2—osteoporosis	8.45e-06	0.00263	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—PGLS—osteoporosis	8.45e-06	0.00263	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	8.08e-06	0.00252	CbGpPWpGaD
Ethylmorphine—OPRM1—TCR Signaling Pathway—IL6—osteoporosis	8.01e-06	0.0025	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	7.97e-06	0.00248	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—CALCR—osteoporosis	7.84e-06	0.00244	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PTH1R—osteoporosis	7.84e-06	0.00244	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—ATIC—osteoporosis	7.73e-06	0.00241	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—PNP—osteoporosis	7.73e-06	0.00241	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—PTH—osteoporosis	7.67e-06	0.00239	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—CNR2—osteoporosis	7.48e-06	0.00233	CbGpPWpGaD
Ethylmorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.37e-06	0.0023	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—POMC—osteoporosis	6.99e-06	0.00218	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—PTH—osteoporosis	6.97e-06	0.00217	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.8e-06	0.00212	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—CNR2—osteoporosis	6.79e-06	0.00212	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—PKM—osteoporosis	6.59e-06	0.00205	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—FDPS—osteoporosis	6.59e-06	0.00205	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—OXCT1—osteoporosis	6.57e-06	0.00205	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—CA2—osteoporosis	6.57e-06	0.00205	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—MGLL—osteoporosis	6.4e-06	0.00199	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—WNT1—osteoporosis	6.38e-06	0.00199	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—PTHLH—osteoporosis	6.36e-06	0.00198	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—PGLS—osteoporosis	6.25e-06	0.00195	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GPD2—osteoporosis	6.25e-06	0.00195	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—MGLL—osteoporosis	6.22e-06	0.00194	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—LRP5—osteoporosis	6.08e-06	0.00189	CbGpPWpGaD
Ethylmorphine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.98e-06	0.00186	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—LRP6—osteoporosis	5.81e-06	0.00181	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—PTHLH—osteoporosis	5.77e-06	0.0018	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—PNP—osteoporosis	5.71e-06	0.00178	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—ATIC—osteoporosis	5.71e-06	0.00178	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—CALCA—osteoporosis	5.6e-06	0.00174	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—IDH2—osteoporosis	5.44e-06	0.0017	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.28e-06	0.00165	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.21e-06	0.00162	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—POMC—osteoporosis	5.18e-06	0.00161	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—CYP27A1—osteoporosis	5.12e-06	0.00159	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—CALCA—osteoporosis	5.08e-06	0.00158	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—ACP5—osteoporosis	4.98e-06	0.00155	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—TLN1—osteoporosis	4.91e-06	0.00153	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—OXCT1—osteoporosis	4.86e-06	0.00151	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—CA2—osteoporosis	4.86e-06	0.00151	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—POMC—osteoporosis	4.86e-06	0.00151	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—MGLL—osteoporosis	4.73e-06	0.00148	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—TPI1—osteoporosis	4.63e-06	0.00144	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—FDPS—osteoporosis	4.58e-06	0.00143	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—PKM—osteoporosis	4.58e-06	0.00143	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—P4HB—osteoporosis	4.35e-06	0.00136	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GPD2—osteoporosis	4.34e-06	0.00135	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—PGLS—osteoporosis	4.34e-06	0.00135	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GAPDH—osteoporosis	4.27e-06	0.00133	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—P4HB—osteoporosis	4.23e-06	0.00132	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—RAP1A—osteoporosis	4.16e-06	0.0013	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PTH—osteoporosis	4.12e-06	0.00128	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—RAP1A—osteoporosis	4.04e-06	0.00126	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—IDH2—osteoporosis	4.03e-06	0.00125	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—CNR2—osteoporosis	4.01e-06	0.00125	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	3.98e-06	0.00124	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—PNP—osteoporosis	3.97e-06	0.00124	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—ATIC—osteoporosis	3.97e-06	0.00124	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—NFATC1—osteoporosis	3.95e-06	0.00123	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—DKK1—osteoporosis	3.91e-06	0.00122	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—CYP27A1—osteoporosis	3.79e-06	0.00118	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—WNT1—osteoporosis	3.77e-06	0.00118	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—ACP5—osteoporosis	3.68e-06	0.00115	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—FGA—osteoporosis	3.67e-06	0.00114	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	3.62e-06	0.00113	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—TPI1—osteoporosis	3.42e-06	0.00107	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PTHLH—osteoporosis	3.41e-06	0.00106	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—BMP2—osteoporosis	3.41e-06	0.00106	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—OXCT1—osteoporosis	3.38e-06	0.00105	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—CA2—osteoporosis	3.38e-06	0.00105	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—ENO1—osteoporosis	3.36e-06	0.00105	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—FGB—osteoporosis	3.34e-06	0.00104	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—PSMA2—osteoporosis	3.31e-06	0.00103	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—PSMA5—osteoporosis	3.31e-06	0.00103	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—MGLL—osteoporosis	3.29e-06	0.00103	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PSMA2—osteoporosis	3.22e-06	0.001	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PSMA5—osteoporosis	3.22e-06	0.001	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—P4HB—osteoporosis	3.22e-06	0.001	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—POMC—osteoporosis	3.18e-06	0.000989	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GAPDH—osteoporosis	3.16e-06	0.000984	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—RAP1A—osteoporosis	3.08e-06	0.000959	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—CALCA—osteoporosis	3e-06	0.000936	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—FDPS—osteoporosis	2.99e-06	0.000933	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—PKM—osteoporosis	2.99e-06	0.000933	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—POMC—osteoporosis	2.93e-06	0.000912	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GPD2—osteoporosis	2.84e-06	0.000885	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—PGLS—osteoporosis	2.84e-06	0.000885	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—IDH2—osteoporosis	2.8e-06	0.000872	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—KL—osteoporosis	2.73e-06	0.00085	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—CYP19A1—osteoporosis	2.69e-06	0.000838	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—POMC—osteoporosis	2.66e-06	0.000829	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.63e-06	0.00082	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—PNP—osteoporosis	2.6e-06	0.000809	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—ATIC—osteoporosis	2.6e-06	0.000809	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—IL6R—osteoporosis	2.59e-06	0.000808	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—ACP5—osteoporosis	2.56e-06	0.000797	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—ENO1—osteoporosis	2.49e-06	0.000775	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—PSMA2—osteoporosis	2.45e-06	0.000764	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—PSMA5—osteoporosis	2.45e-06	0.000764	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—TPI1—osteoporosis	2.38e-06	0.000741	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—P4HB—osteoporosis	2.24e-06	0.000697	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.21e-06	0.000688	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—CA2—osteoporosis	2.21e-06	0.000688	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—ADCY5—osteoporosis	2.2e-06	0.000684	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GAPDH—osteoporosis	2.2e-06	0.000684	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GPX1—osteoporosis	2.19e-06	0.000682	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—MGLL—osteoporosis	2.15e-06	0.00067	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—RAP1A—osteoporosis	2.14e-06	0.000666	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—ADCY5—osteoporosis	2.14e-06	0.000665	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—SPP1—osteoporosis	2.07e-06	0.000644	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—MTHFR—osteoporosis	2.02e-06	0.00063	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.99e-06	0.00062	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IRS2—osteoporosis	1.87e-06	0.000582	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—IDH2—osteoporosis	1.83e-06	0.00057	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—LEP—osteoporosis	1.83e-06	0.00057	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—ESR1—osteoporosis	1.75e-06	0.000544	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—ENO1—osteoporosis	1.73e-06	0.000539	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.72e-06	0.000536	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.7e-06	0.000531	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.7e-06	0.000531	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—ACP5—osteoporosis	1.67e-06	0.000521	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IRS1—osteoporosis	1.63e-06	0.000508	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—ADCY5—osteoporosis	1.62e-06	0.000506	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GPX1—osteoporosis	1.62e-06	0.000504	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—POMC—osteoporosis	1.62e-06	0.000503	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—POMC—osteoporosis	1.57e-06	0.000489	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—TPI1—osteoporosis	1.56e-06	0.000485	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IL6R—osteoporosis	1.53e-06	0.000477	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IGF1—osteoporosis	1.51e-06	0.000471	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—MTHFR—osteoporosis	1.49e-06	0.000466	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—P4HB—osteoporosis	1.46e-06	0.000456	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.44e-06	0.000447	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.4e-06	0.000436	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.38e-06	0.000431	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—POMC—osteoporosis	1.19e-06	0.000372	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—IL6—osteoporosis	1.16e-06	0.00036	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—ENO1—osteoporosis	1.13e-06	0.000352	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.13e-06	0.000352	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GPX1—osteoporosis	1.13e-06	0.000351	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.11e-06	0.000347	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.11e-06	0.000347	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.04e-06	0.000324	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—MYC—osteoporosis	9.08e-07	0.000283	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—TGFB1—osteoporosis	9.06e-07	0.000282	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.04e-07	0.000282	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—POMC—osteoporosis	8.31e-07	0.000259	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—ADCY5—osteoporosis	7.38e-07	0.00023	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GPX1—osteoporosis	7.36e-07	0.000229	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IL6—osteoporosis	6.83e-07	0.000213	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.79e-07	0.000212	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—POMC—osteoporosis	5.43e-07	0.000169	CbGpPWpGaD
